Validation and clinical application of a high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the quantitative determination of 10 anti-retrovirals in human peripheral blood mononuclear cells

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 20-21, 2009, Pages 1805-1814

  Elens, L ^a   Veriter, S ^a   Yombi, J C ^b   Di Fazio, V ^b   Vanbinst, R ^b   Lison, D ^a   Wallemacq, P ^a,b   Vandercam, B ^b   Haufroid, V ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Anti HIV drugs; Human peripheral blood mononuclear cells; Isotopic dilution; Liquid chromatography tandem mass spectrometry; Quantitative determination

Indexed keywords

ANTI-HIV DRUGS; HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS; ISOTOPIC DILUTION; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; QUANTITATIVE DETERMINATION;

ABERRATIONS; BLOOD; CELL MEMBRANES; CENTRIFUGATION; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION OF LIQUIDS; ISOTOPES; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; METHANOL; PATIENT MONITORING; SPECTRUM ANALYSIS;

HIGH PRESSURE LIQUID CHROMATOGRAPHY;

AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CELL EXTRACT; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; MARAVIROC; METHANOL; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; TENOFOVIR; TIPRANAVIR;

ARTICLE; CALIBRATION; DENSITY GRADIENT CENTRIFUGATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IONIZATION; MAJOR CLINICAL STUDY; MOLECULE; MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

ADULT; ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

PEPPER GOLDEN MOSAIC VIRUS - [MEXICO];

EID: 67049134607     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.04.046     Document Type: Article

References (50)

1. Ford J., Cornforth D., Hoggard P.G., Cuthbertson Z., Meaden E.R., Williams I., Johnson M., Daniels E., Hsyu P., Back D.J., and Khoo S.H. Antivir. Ther. 9 (2004) 77
2. Ford J., Boffito M., Wildfire A., Hill A., Back D., Khoo S., Nelson M., Moyle G., Gazzard B., and Pozniak A. Antimicrob. Agents Chemother. 48 (2004) 2388
3. Colombo S., Telenti A., Buclin T., Furrer H., Lee B.L., Biollaz J., and Decosterd L.A. Ther. Drug Monit. 28 (2006) 332
4. Djabarouti S., Breilh D., Pellegrin I., Lavit M., Camou F., Caubet O., Fleury H., Saux M.C., and Pellegrin J.L. J. Antimicrob. Chemother. 58 (2006) 1090
5. Colombo S., Beguin A., Telenti A., Biollaz J., Buclin T., Rochat B., and Decosterd L.A. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 819 (2005) 259
6. Ehrhardt M., Mock M., Haefeli W.E., Mikus G., and Burhenne J. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 850 (2007) 249
7. Jemal M., Rao S., Gatz M., and Whigan D. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 795 (2003) 273
8. Pelerin H., Compain S., Duval X., Gimenez F., Benech H., and Mabondzo A. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 819 (2005) 47
9. Rouzes A., Berthoin K., Xuereb F., Djabarouti S., Pellegrin I., Pellegrin J.L., Coupet A.C., Augagneur S., Budzinski H., Saux M.C., and Breilh D. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 813 (2004) 209
10. Crommentuyn K.M., Rosing H., Nan-Offeringa L.G., Hillebrand M.J., Huitema A.D., and Beijnen J.H. J. Mass Spectrom. 38 (2003) 157
11. Crommentuyn K.M., Rosing H., Hillebrand M.J., Huitema A.D., and Beijnen J.H. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 804 (2004) 359
12. D'Avolio A., Siccardi M., Sciandra M., Baietto L., Bonora S., Trentini L., and Di Perri G. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 859 (2007) 234
13. Dickinson L., Robinson L., Tjia J., Khoo S., and Back D. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 829 (2005) 82
14. Ghoshal A.K., and Soldin S.J. Ther. Drug Monit. 25 (2003) 541
15. Jung B.H., Rezk N.L., Bridges A.S., Corbett A.H., and Kashuba A.D. Biomed. Chromatogr. 21 (2007) 1095
16. Rentsch K.M. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 788 (2003) 339
17. Schuster A., Burzawa S., Jemal M., Loizillon E., Couerbe P., and Whigan D. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 788 (2003) 377
18. ter Heine R., Alderden-Los C.G., Rosing H., Hillebrand M.J., van Gorp E.C., Huitema A.D., and Beijnen J.H. Rapid Commun. Mass Spectrom. 21 (2007) 2505
19. Villani P., Feroggio M., Gianelli L., Bartoli A., Montagna M., Maserati R., and Regazzi M.B. Ther. Drug Monit. 23 (2001) 380
20. Volosov A., Alexander C., Ting L., and Soldin S.J. Clin. Biochem. 35 (2002) 99
21. Wang P.G., Wei J.S., Kim G., Chang M., and El Shourbagy T. J. Chromatogr. A 1130 (2006) 302
22. Almond L.M., Edirisinghe D., Dalton M., Bonington A., Back D.J., and Khoo S.H. Clin. Pharmacol. Ther. 78 (2005) 132
23. Chaillou S., Durant J., Garraffo R., Georgenthum E., Roptin C., Clevenbergh P., Dunais B., Mondain V., Roger P.M., and Dellamonica P. HIV Clin. Trials 3 (2002) 493
24. Crommentuyn K.M., Mulder J.W., Mairuhu A.T., van Gorp E.C., Meenhorst P.L., Huitema A.D., and Beijnen J.H. Antivir. Ther. 9 (2004) 779
25. Hennessy M., Clarke S., Spiers J.P., Kelleher D., Mulcahy F., Hoggard P., Back D., and Barry M. Antivir. Ther. 9 (2004) 115
26. Khoo S.H., Hoggard P.G., Williams I., Meaden E.R., Newton P., Wilkins E.G., Smith A., Tjia J.F., Lloyd J., Jones K., Beeching N., Carey P., Peters B., and Back D.J. Antimicrob. Agents Chemother. 46 (2002) 3228
27. Meaden E.R., Hoggard P.G., Newton P., Tjia J.F., Aldam D., Cornforth D., Lloyd J., Williams I., Back D.J., and Khoo S.H. J. Antimicrob. Chemother. 50 (2002) 583
28. Solas C., Li Y.F., Xie M.Y., Sommadossi J.P., and Zhou X.J. Antimicrob. Agents Chemother. 42 (1998) 2989
29. Moore J.D., Valette G., Darque A., Zhou X.J., and Sommadossi J.P. J. Am. Soc. Mass Spectrom. 11 (2000) 1134
30. FDA, 2001. http://fda.gov/cder/guidance/index.htm.
31. Furman P.A., Fyfe J.A., St Clair M.H., Weinhold K., Rideout J.L., Freeman G.A., Lehrman S.N., Bolognesi D.P., Broder S., and Mitsuya H. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 8333
32. Elens L., Veriter S., Di Fazio V., Vanbinst R., Boesmans D., Wallemacq P., and Haufroid V. Clin. Chem. 55 (2009) 170
33. Azoulay S., Nevers M.C., Créminon C., Heripret L., Durant J., Dellamonica P., Grassi J., Guedj R., and Duval D. Antimicrob. Agents Chemother. 48 (2004) 104
34. Ford J., Boffito M., Maitland D., Hill A., Back D., Khoo S., Nelson M., Moyle G., Gazzard B., and Pozniak A. J. Antimicrob. Chemother. 58 (2006) 1009
35. Breilh D., Pellegrin I., Rouzés A., Berthoin K., Xuereb F., Budzinski H., Munck M., Fleury H.J., Saux M.C., and Pellegrin J.L. AIDS 18 (2004) 1305
36. Becher F., Schlemmer D., Pruvost A., Nevers M.C., Goujard C., Jorajuria S., Guerreiro C., Brossette T., Lebeau L., Creminon C., Grassi J., and Benech H. Anal. Chem. 74 (2002) 4220
37. Fu I., Woolf E.J., and Matuszewski B.K. J. Pharm. Biomed. Anal. 18 (1998) 347
38. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
39. King J.R., Wynn H., Brundage R., and Acosta E.P. Clin. Pharmacokinet. 43 (2004) 291
40. Smith P.F., DiCenzo R., and Morse G.D. Clin. Pharmacokinet. 40 (2001) 893
41. López-Cortés L.F., Ruiz-Valderas R., Marín-Niebla A., Pascual-Carrasco R., Rodríguez-Díez M., and Lucero-Muñoz M.J. J. Acquir. Immune Defic. Syndr. 39 (2005) 551
42. Hoggard P., Meaden E., and Tjia J. Sixth International Congress on Drug Therapy in HIV Infection. Glasgow, UK (2002) (Abstract PL8.2)
43. Kappelhoff B.S., Crommentuyn K.M., de Maat M.M., Mulder J.W., Huitema A.D., and Beijnen J.H. Clin. Pharmacokinet. 43 (2004) 845
44. MacGregor T.R., Sabo J.P., Norris S.H., Johnson P., Galitz L., and McCallister S. HIV Clin. Trials 5 (2004) 371
45. King J.R., and Acosta E.P. Clin. Pharmacokinet. 45 (2006) 665
46. Mukwaya G., MacGregor T., Hoelscher D., Heming T., Legg D., Kavanaugh K., Johnson P., Sabo J.P., and McCallister S. Antimicrob. Agents Chemother. 49 (2005) 4903
47. Lang T., Klein K., Fischer J., Nüssler A.K., Neuhaus P., Hofmann U., Eichelbaum M., Schwab M., and Zanger U.M. Pharmacogenetics 11 (2001) 399
48. Klein K., Lang T., Saussele T., Barbosa-Sicard E., Schunck W.H., Eichelbaum M., Schwab M., and Zanger U.M. Pharmacogenet. Genomics 15 (2005) 861
49. Desta Z., Saussele T., Ward B., Blievernicht J., Li L., Klein K., Flockhart D.A., and Zanger U.M. Pharmacogenomics 8 (2007) 547
50. Zanger U.M., Klein K., Saussele T., Blievernicht J., Hofmann M.H., and Schwab M. Pharmacogenomics 8 (2007) 743